Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators

被引:0
|
作者
Vargas-Roldan, Silvia Y. [1 ,2 ]
Lezana-Fernandez, Jose L. [3 ,4 ]
Cerna-Cortes, Jorge F. [2 ]
Partida-Sanchez, Santiago [5 ,6 ]
Santos-Preciado, Jose, I [1 ]
Rosales-Reyes, Roberto [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico
[2] Inst Politecn Nacl, Dept Microbiol, Lab Microbiol Mol, Escuela Nacl Ciencias Biol, Ciudad De Mexico, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Lab Fisiol Respiratoria & Clin Fibrosis Quist, Ciudad De Mexico, Mexico
[4] Assoc Mexicana Fibrosis Quist, Direcc Med, Ciudad De Mexico, Mexico
[5] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Abigail Wexner Res Inst, Columbus, OH USA
[6] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Burkholderia cenocepacia; CFTR modulators; VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; ADAPTATION; POTENTIATOR; IVACAFTOR;
D O I
10.24875/BMHIM.21000128
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cystic fibrosis is an autosomal recessive inherited disease caused by mutations in the cystic fibrosis transmembrane con-ductance regulator gene (CFTR). CFTR is a protein that transports ions across the membrane of lung epithelial cells. Loss of its function leads to the production of thick sticky mucus, where various bacterial pathogens can establish and adapt, contributing to the gradual loss of lung function. In this review, evidence of the molecular mechanisms used by Pseudomonas aeruginosa and Burkholderia cenocepacia to survive and persist in the pulmonary environment will be provided. Additionally, new therapeutic strategies based on CFTR function modulators will be described.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 50 条
  • [31] Beneficial effect of cystic fibrosis transmembrane conductance regulator modulators on adults with cystic fibrosis liver disease
    Manioudaki, Sofia
    Vasilieva, Larisa
    Mani, Ilianna
    Diamantea, Filia
    Alexopoulos, Theodoros
    Pouriki, Sophia
    Athanassa, Zoe
    Sakagianni, Aikaterini
    Geladari, Eleni
    Elefsiniotis, Ioannis
    Hadziyannis, Emilia
    Alexopoulou, Alexandra
    JOURNAL OF HEPATOLOGY, 2023, 78 : S978 - S979
  • [32] Cystic fibrosis transmembrane conductance regulator modulators: Present and future in cystic fibrosis treatment. A review
    De la Hoz, Diana
    Villamil Osorio, Milena
    Restrepo-Gualteros, Sonia M.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (02): : E131 - E135
  • [33] Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis Progress to Date
    Becq, Frederic
    DRUGS, 2010, 70 (03) : 241 - 259
  • [34] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Ramsey, Mitchell L.
    Wellner, Michael R.
    Porter, Kyle
    Kirkby, Stephen E.
    Li, Susan S.
    Lara, Luis F.
    Kelly, Sean G.
    Hanje, A. James
    Sobotka, Lindsay A.
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 411 - 419
  • [35] Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
    Mitchell L Ramsey
    Michael R Wellner
    Kyle Porter
    Stephen E Kirkby
    Susan S Li
    Luis F Lara
    Sean G Kelly
    A James Hanje
    Lindsay A Sobotka
    World Journal of Hepatology, 2022, (02) : 411 - 419
  • [36] The Role of Cystic Fibrosis Transmembrane Conductance Regulator Modulators After Liver Transplantation in Persons With Cystic Fibrosis
    Maradiaga, Richard
    Ramsey, Mitchell
    Kirkby, Stephen
    Sobotka, Lindsay
    ACG CASE REPORTS JOURNAL, 2024, 11 (01)
  • [37] Cystic Fibrosis Transmembrane Conductance Regulator Modulators Reduce Hospitalizations for Acute Pancreatitis in Patients With Cystic Fibrosis
    Ramsey, M. L.
    Sobotka, L. A.
    Wellner, M. R.
    Porter, K.
    Lara, L. F.
    PANCREAS, 2020, 49 (10) : 1425 - 1426
  • [38] EXCESS FLUORIDE INTERFERENCE WITH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    Clinch, Carole
    FLUORIDE, 2011, 44 (01) : 7 - 8
  • [39] The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel.
    Hanrahan, JW
    Zhu, T
    Dahan, D
    Fung, S
    Meredith, J
    Phillips, JE
    AMERICAN ZOOLOGIST, 2000, 40 (06): : 1046 - 1046
  • [40] Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis
    Ooi, Chee Y.
    Durie, Peter R.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (05) : 355 - 362